Clinical Trials Directory

Trials / Unknown

UnknownNCT03706508

Pentafecta Outcomes After Robot-assisted Laparoscopic Radical Prostatectomy

Pentafecta Outcomes After Robot-assisted Laparoscopic Radical Prostatectomy: First 120 Cases in Brazilian University Hospital

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Hospital de Clinicas de Porto Alegre · Academic / Other
Sex
Male
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Robot-assisted laparoscopic radical prostatectomy (RALRP) is a surgical technique for the treatment of prostate cancer. The aim of this study was to report our initial experience with RALRP, by applying the concept of pentafecta. Pentafecta consists of the five main outcomes in the postoperative period of RALRP: erectile dysfunction, urinary incontinence, postoperative complications, surgical margins and biochemical failure.

Detailed description

This study will describe a initial experience in RALRP in Brazilian University Hospital. The follow-up of patients was performed as an examination at the medical consultation every three months. Complications were categorized according to the Clavien classification system. Biochemical failure was established by PSA level. Continence was defined as patients who remain dry and who do not require any kind of protection in their everyday activities. Sexual potency was defined as the ability to get and keep an erection for long enough to have satisfying sexual relations with or without the use of type-5 phosphodiesterase inhibitors (PDE-5) and a Sexual Health Inventory for Men (SHIM) score greater or equal to 21. Positive surgical margin is defined as the presence of neoplastic glands in direct contact with the ink on the surface of the piece, with no interposed connective tissue.

Conditions

Interventions

TypeNameDescription
PROCEDURERobot-assisted laparoscopic radical prostatectomyPatients with localized prostate cancer underwent transperitoneal robot-assisted laparoscopic radical prostatectomy

Timeline

Start date
2013-08-09
Primary completion
2018-11-30
Completion
2018-11-30
First posted
2018-10-16
Last updated
2018-10-30

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03706508. Inclusion in this directory is not an endorsement.